HANSOH PHARMAC. HD-00001 (3KY) — Defensive Interval Ratio
HANSOH PHARMAC. HD-00001 (3KY) has a Defensive Interval Ratio of 254 days as of December 2025. Defensive assets of €3.06 Billion (cash €-, short-term investments €17.61 Million, receivables €3.04 Billion) cover 254 days of daily cash needs of €12.04 Million/day. See 3KY working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
HANSOH PHARMAC. HD-00001 Defensive Interval Ratio (2021–2025)
This chart shows how HANSOH PHARMAC. HD-00001's Defensive Interval Ratio has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 254 days, meaning defensive assets of €3.06 Billion can fund 254 days of operations without new revenue. Read 3KY total liabilities for a breakdown of total debt and financial obligations.
Annual Defensive Interval Ratio for HANSOH PHARMAC. HD-00001 (2021–2025)
The table below presents the year-by-year Defensive Interval Ratio for HANSOH PHARMAC. HD-00001 from 2021 to 2025, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For the complete balance sheet picture, see balance sheet size of HANSOH PHARMAC. HD-00001.
| Year | DIR (days) | Defensive Assets (EUR) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 254 days | €3.06 Billion | €12.04 Million/day | €- | €17.61 Million | ▼ -273 days |
| 2024 | 527 days | €3.89 Billion | €7.38 Million/day | €- | €764.71 Million | ▲ +228 days |
| 2023 | 300 days | €5.63 Billion | €18.80 Million/day | €- | €2.42 Billion | ▼ -751 days |
| 2022 | 1051 days | €7.54 Billion | €7.18 Million/day | €- | €4.01 Billion | ▲ +148 days |
| 2021 | 903 days | €7.48 Billion | €8.28 Million/day | €- | €4.23 Billion | — |